N/A
N=112
The Need of Fiberoptic Bronchoscopy for Placing an Endobronchial Blocker
Neoplasms, Pulmonary · Thoracic Diseases
Bottom Line
View on ClinicalTrials.gov: NCT02133235 ↗Enrolled (actual)
112
Serious AEs
0.0%
Results posted
Nov 2015
Primary outcome: Primary: Surgical Grading for Lung Isolation — 12; 13; 15; 14 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- conventional (Procedure); auscultation (Procedure)
- Age
- Adult, Older Adult · 20+ yrs
- Sex
- All
- Sponsor
- National Taiwan University Hospital
- Primary completion
- Jun 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Surgical Grading for Lung Isolation |
12; 13; 15; 14; 10; 11 | — |
| PRIMARY Time Required for Proper Placement of the Endobronchial Blocker |
138.5; 130; 89.6; 141.1 | — |
Summary
The need of fiberoptic bronchoscopy for placing an endobronchial blocker. Endobronchial blockers (EBB) have been presented effective and safe alternative for lung separation in vedio-assisted thoracoscopic (VATS) operations. In this study, the investigators will randomize the patients receiving VATS operation with EBB into two groups: one group will receive the conventional bronchoscopic guided EBBs placement, the other group receive two step procedure without confirmation by fiberoptic bronchoscopy.
Eligibility Criteria
Inclusion criteria
Lung separation by endobronchial blockers
Exclusion criteria
Lung separation by conventional double lumen tube Lung separation with endobronchial blockers through
Data sourced from ClinicalTrials.gov (NCT02133235). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.